PEAK6 Group’s Core Laboratories CLB Stock Holding History

PEAK6 Group’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$195K	Buy	1,544 +612	+66%	+$74.5K	﹤0.01%	3356
2018 Q1	$101K	Buy	+932	New	+$103K	﹤0.01%	3703
2017 Q3	–	Sell	-8,221	Closed	-$797K	–	4451
2017 Q2	$833K	Buy	8,221 +3,668	+81%	+$395K	﹤0.01%	2082
2017 Q1	$526K	Buy	+4,553	New	+$529K	﹤0.01%	2218
2016 Q4	–	Sell	-4,054	Closed	-$449K	–	4737
2016 Q3	$455K	Buy	+4,054	New	+$467K	﹤0.01%	2414
2016 Q1	–	Sell	-2,951	Closed	-$321K	–	4455
2015 Q4	$321K	Sell	2,951 -8,229	-74%	-$942K	﹤0.01%	3002
2015 Q3	$1.12M	Buy	11,180 +5,477	+96%	+$596K	0.01%	2088
2015 Q2	$650K	Buy	+5,703	New	+$692K	﹤0.01%	2480
2015 Q1	–	Sell	-13,766	Closed	-$1.47M	–	4772
2014 Q4	$1.66M	Sell	13,766 -3,064	-18%	-$402K	0.01%	1504
2014 Q3	$2.46M	Buy	16,830 +15,198	+931%	+$2.35M	0.02%	1088
2014 Q2	$273K	Sell	1,632 -52	-3%	-$9.25K	﹤0.01%	2904
2014 Q1	$334K	Sell	1,684 -2,041	-55%	-$385K	﹤0.01%	2927
2013 Q4	$711K	Buy	+3,725	New	+$693K	0.01%	2345

Other funds holding CLB

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

PEAK6 Group's CLB Position: Q2 2018 in Review

PEAK6 Group increased its Core Laboratories (CLB) stake by 66% in Q2 2018, buying an estimated $74.5K and bringing the position to 1,544 shares worth $195K. The position accounts for ﹤0.01% of the portfolio, ranked #3356.

PEAK6 Group first reported a position in CLB in Q4 2013 and has held it in 13 quarters since. The position peaked at $2.46M in Q3 2014. 374 funds tracked by Wall St. Rank hold CLB as of Q2 2018.

PEAK6 Group held 1,544 shares of Core Laboratories worth $195K as of Q2 2018.
PEAK6 Group bought 612 Core Laboratories shares in Q2 2018, an estimated $74.5K.
Core Laboratories made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #3356 holding.
PEAK6 Group first reported a position in Core Laboratories in Q4 2013 and has held it in 13 quarters since.
PEAK6 Group's Core Laboratories position peaked at $2.46M in Q3 2014.
374 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.